Most people have never heard of α-Klotho. But the scientific community has been quietly obsessed with it since 1997, when ...

A wave of spatial transcriptomics studies has produced gene-expression atlases that span entire organs and whole organisms, ...

Organogenesis Holdings Inc. looks undervalued at distressed multiples; new DFU RCT data supports coverage despite 2026 CMS ...

Shares of Organogenesis Holdings were higher after the company said its product for non-healing diabetic foot ulcers met its primary endpoint in a recent trial. The stock rose 30%, to $2.91, in ...

Organogenesis has experienced a ~50% share price decline since December 2025, presenting a potential value opportunity. Click ...

Organogenesis Holdings Inc. ORGO shares are up during Tuesday’s premarket session following the company’s announcement of achieving the primary endpoint in a randomized controlled trial evaluating ...

Organogenesis Holdings said its product for non-healing diabetic foot ulcers met the primary endpoint in a recent trial. The medicine company said Monday that PuraPly plus standard of care (SOC) ...

For the first time, researchers have simulated the full workings of a bacterial cell as it copies its DNA and divides into two. The experiment could help researchers to understand how the interactions ...

The shares were purchased at a price of $2.681, totaling $13,405. Following the transaction, Leibowitz directly owns 291,014 shares of Organogenesis Holdings Inc.The insider purchase comes as ORGO ...

Cedars-Sinai Health Sciences University investigators have for the first time created human intestinal organoids that include ...

Researchers have uncovered new insights into the early development of baby stars. As published in The Astrophysical Journal ...